The supportive and symptomatic care of patients with multiple myeloma is extremely important in maintaining their quality of life. This guideline systematically reviews and provides guidance on the management of the commonest complications of myeloma and its treatment. The complications for which specific management is recommended include anaemia, pain, bone disease, infection, anaemia, peripheral neuropathy, venous thrombosis and fatigue. There are additonal sections on complementary therapies and end of life care.
Declaration of Interests
The BSH paid the expenses incurred during the writing of this guidance. None of the authors had conflicts of interest to declare. All authors have made a declaration of interests to the BSH and Task Force Chairs which may be viewed on request.